Review of Low-Dose RT for Osteoarthritis

Interactive Webcast on Thursday, September 1, at 11 AM EDT

Despite its clinical use and investigation in other countries, low dose radiotherapy (LDRT) in the treatment of osteoarthritis (OA) is minimally used in the United States (US). Numerous recent studies published outside the US have shown moderate to long-term pain relief and improvement of mobility following treatment with LDRT for joints affected by OA.

Join Xstrahl and Dr. Austin Dove, radiation oncologist from Vanderbilt University Medical Center, as he reviews the most recent literature published on the use of LDRT in OA. Dr. Dove will briefly outline how OA impacts patients in the United States, discuss criticisms of the use of LDRT related to secondary malignancies, and highlight recommendations on dose and fractionation, energy, beam arrangements, and immobilization techniques. Dr. Dove will also be available for Q&A following the presentation.


Register Now: